Diabetic peripheral neuropathy: How reliable is a homemade 1-g monofilament for screening?

Journal of Family Practice

Volumn 55, Issue 6, 2006, Pages 505-508

  Bourcier, Matthew E ^a   Ullal, Jagdeesh ^a   Parson, Henri K ^a   Dublin, Charlotte B ^a   Witherspoon, Crystal A G ^a   Ward, Sheila A ^b   Vinik, Aaron I ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b NORFOLK STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANALYSIS OF VARIANCE; ARTICLE; CASE CONTROL STUDY; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; MONOFILAMENT TEST; PERIPHERAL NEUROPATHY; PRACTICE GUIDELINE; QUESTIONNAIRE; SCREENING TEST; SENSITIVITY AND SPECIFICITY;

ADULT; ALGORITHMS; COMPRESSIVE STRENGTH; DIABETIC NEUROPATHIES; FEMALE; HUMANS; HYPESTHESIA; MALE; MANUFACTURED MATERIALS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SENSORY THRESHOLDS;

EID: 33745128070     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Preventive foot care in diabetes. Diabetes Care 2004; 27:63S-664.
2. Boulton AJ, Wnik A, Arezzo J, et al. Position statement: diabetic neuropathies. Diabetes Care 2005; 28:956-962.
3. Birke JA, Rotfsen RJ. Evaluation of a self-administered sensory testing tool to identify patients at risk of diabetes-related foot problems. Diabetes Care 1998; 21:23-25.
4. McGill M, Molyneaux L, Spencer R, Heng LF, Yue DK. Possible sources of discrepancies in the use of the Semmes-Weinstein monofilament. Diabetes Care 1999; 22:598-602.
5. Adler AI, Boyko EJ, Ahroni JH, Smith DG. Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers. Diabetes Care 1999; 22:1029-1035.
6. Armstrong DG, Lavery LA, Vela SA, Quebedeaux TL, Reischli JG. Choosing a practical screening instrument to identify patients at risk for diabetic foot ulceration. Arch Intern Med 1998; 158:289-292.
7. Consensus State: Report and recommendations of the San Antonio conference on diabetic neuropathy. American Diabetes Association American Academy of Neurology. Diabetes Care 1988; 11:592-597.
8. Consensus State: Proceedings of a consensus development conference on standardized measures in diabetic neuropathy. Muscle Nerve 1992; 15:1143-1170.
9. McGill M, Molyneaux L, Yue DK. Use of the Semmes-Weinstein 5.07/10 gram monofilament: the long and the short of it. Diabetes Med 1998; 15:615-617.
10. Mueller MJ. Identifying patients with diabetes mellitus who are at risk for lower-extremity complications: use of Semmes-Weinstein monofilaments. Phys Ther 1996; 76:68-71.
11. Kumar S, Fernando DJ, Veves A, Knowles EA, Young MJ, Boulton AJ. Semmes-Weinstein monofilaments: a simple, effective and inexpensive screening device for identifying diabetic patients at risk of foot ulceration. Diabetes Res Clin Pract 1991; 13:63-67.
12. Vinik AI, Suwanwalaikom S, Stansberry KB, Holland MT, McNitt PM, Colen LE. Quantitative measurement of cutaneous perception in diabetic neuropathy. Muscle Nerve 1995; 18:574-584.
13. Krans HH, Perta M, Keen K. The St Vincent declaration action programme. Eurodiabcare 1992; Diabetes Care and Research in Europe. WHO.
14. Piart J. Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973. Diabetes Care 1978; 1:252-263.
15. McGill M, Molyneaux L, Spencer R, Heng LF, Yue DK. Possible sources of discrepancies in the use of the Semmes-Weinstein monofilament. Impact on prevalence of insensate foot and workload requirements. Diabetes Care 1999; 22:598-602.
16. McGill M, Molyneaux L, Yue DK. Use of the Semmes-Weinstein 5.07/10 gram monofilament: the long and the Short of it. Diabetes Med 1998; 15:615-617
17. Litzelman DK, Mamott DJ, Vinicor F. Independent physiological predictors of foot lesions in patients with NIDDM. Diabetes Care 1997; 20:1273-1278.
18. Shearer A, Scuffham P, Gordois A, Oglesby A. Predicted costs and outcomes from reduced vibration detection in people with diabetes in the U.S. Diabetes Care 2003; 26:2305-2310.
19. Siao P, Gros DP. Quantitative sensory testing. Phys Med Rehabil Clin N Am 2003; 14:261-286.